In our previous articles, we introduced the shift from orchestration software to what we define as Intelligent Infrastructure for Science and explored the first four capabilities that enable organizations to manage external R&D as a connected system.
Together, those capabilities define how work enters the system, how it is executed, how it is paid for, and how performance is measured. But none of them can deliver their full value unless the system itself can adapt to the organization using it—and connect seamlessly to the broader technology ecosystem around it.
This is where the final two capabilities become critical: Customization & Automation and System Integration & Data Flow.
Most R&D platforms force organizations to adapt to the system—but the real question is whether your platform can adapt to you.The Challenge: When the Organization Has to Adapt to the System
No two pharmaceutical organizations manage external R&D the same way. Therapeutic area structures, governance models, supplier strategies, and compliance requirements vary significantly across organizations and evolve continuously over time.
Yet many platforms are designed around rigid workflows and predefined operating models. Approval logic is fixed, sourcing rules are difficult to modify, and changes often require development work or lengthy implementation cycles.
When the platform cannot adapt, organizations inevitably work around it. Teams move back into spreadsheets and email, build parallel processes outside the system, and create manual exceptions that reduce both adoption and long-term value.
Over time, the system that was intended to simplify operations becomes another constraint.
Capability 5: Customization & Automation
A modern R&D operations platform should not force organizations into a predefined way of working. Instead, the system should adapt to how the organization operates.
This capability includes:
- No-code workflow configuration
Administrators can modify workflows, routing rules, and approval logic without requiring engineering resources or IT support. - Custom sourcing strategies and supplier rules
Preferred suppliers, classifications, and routing logic can be configured by therapeutic area, geography, or strategic priorities. - Dynamic forms and custom data structures
Organizations can capture the information that matters to their specific workflows and reporting requirements. - Complex approval logic and automation
Parallel approvals, conditional routing, and automated task creation reflect real organizational decision-making processes. - Automation of repetitive operational work
High-volume activities (e.g., notifications, reminders, financial workflows and analytics, and requalification workflows) run automatically.
When customization and automation are treated as foundational capabilities rather than professional services projects, the system becomes an enabler rather than a limitation. Processes evolve without requiring large implementation efforts, and organizations can scale without adding operational complexity.
Just as importantly, automation begins to compound over time. The more routine work the system absorbs, the more teams can focus on strategic priorities rather than administration.
The Next Challenge: When Platforms Create New Silos
Even highly configurable systems can create problems if they operate independently from the broader enterprise environment.
This remains a common challenge in external R&D. Organizations introduce a new operational platform, but it fails to connect cleanly to ERP systems, procurement infrastructure, or internal systems of record. The result is a different form of fragmentation, one that exists not within workflows, but across the architecture itself. For large organizations, this often determines whether a platform can scale beyond an initial deployment.
Integration isn't a nice-to-have in external R&D—it's what separates a platform that scales from one that creates new silos.Capability 6: System Integration & Data Flow
A cohesive R&D operations platform should not operate as an isolated destination. It should function as a connected layer within the broader enterprise environment.
This capability includes:
- Single sign-on and unified access
Users authenticate through existing enterprise identity systems without maintaining separate credentials. - Bi-directional synchronization across systems
Supplier data, purchase orders, and financial records remain synchronized automatically. - Compatibility with enterprise systems
Integration with ERP, procurement, and CRM systems reduces duplicate work and improves continuity across functions. - API access and extensibility
Organizations can extend the platform into internal systems and custom workflows. - Enterprise-grade security and compliance
Security certifications, access controls, encryption, and data residency requirements support enterprise deployment.
When integration is treated as foundational rather than optional, the platform becomes part of the organization's infrastructure rather than another application that requires ongoing maintenance and reconciliation.
Data flows naturally across systems, operational overhead is reduced, and IT teams gain a platform that fits into long-term architecture rather than competing with it.
Concluding Remarks
For many organizations, customization and integration are still evaluated late in the buying process, often as technical considerations addressed after feature comparisons are complete. But increasingly, they determine whether a platform can deliver durable value at scale.
The six capabilities outlined across this series describe more than a set of product requirements. Together, they define a different operating model, one where external R&D functions as a connected system rather than a collection of point solutions stitched together through process. As scientific complexity continues to increase and technology continues to advance, the systems supporting R&D must evolve alongside it.
That is the standard Intelligent Infrastructure for Science is designed to meet.
